Brief OpinionThoracic Radiation Therapy During Coronavirus Disease 2019: Provisional Guidelines from a Comprehensive Cancer Center within a Pandemic Epicenter
Cited by (0)
Sources of support: This research was supported in part by NIH P30 CA008748.
Disclosures: Dr Wu has received research funding from CivaTech Oncology, Inc, personal fees from AstraZeneca, and travel grants from AlphaTau, Medical. Dr Rimner has received research funding from Varian Medical Systems, AstraZeneca, Boehringer Ingelheim, Pfizer, and Merck; personal fees from AstraZeneca, Merck, Research to Practice, Cybrexa, and More Health; and nonfinancial support from Philips/Elekta. Dr Simone has received personal fees from Varian Medical Systems. Dr Gomez has received research funding from Boehringer Ingelheim, Varian Medical Systems, AstraZeneca, Merck, and Bristol-Myers Squibb and personal fees from Varian Medical Systems, AstraZeneca, Merck, Bristol-Myers Squibb, US Oncology, Reflexion, WebMD, Vindico, and Medscape and serves on an advisory board for AstraZeneca.